Search company, investor...
Psyomics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Unattributed VC - III | Alive

Total Raised


Last Raised

$2.94M | 3 mos ago

Mosaic Score

+90 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Psyomics

Psyomics develops clinical products to make mental health diagnosis faster and more accurate. The approach is based around a patient-facing digital diagnostic tool that uses algorithms to replicate the diagnostic process used by clinical psychiatrists. Where appropriate, this is combined with a blood-spot test kit that’s used to detect the protein signatures of certain mental health conditions, identified through groundbreaking studies at the Cambridge Centre for Neuropsychiatric Research (CCNR). Psyomics was founded in 2015 and is based in Cambridge, England.

Psyomics Headquarters Location

Cambridge Innovation Centre, 23 Cambridge Science Park Milton Road

Cambridge, England, CB4 0EY,

United Kingdom

+44 (0) 1233 437131

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Psyomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Psyomics is included in 5 Expert Collections, including Mental Health Tech.


Mental Health Tech

1,246 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.


Medical Devices

8,487 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,412 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

7,901 items

Latest Psyomics News

Hertfordshire Partnership uses digital mental health assessment platform

Sep 15, 2022

Hertfordshire Partnership University NHS Foundation Trust (HPFT) has teamed up with Psyomics, an evidence-based mental health assessment platform, to improve the support that is available for adults with mental health conditions. Hertfordshire Partnership University will be using Censeo, a digital health tool from Psyomics, which helps to use clinicians’ time effectively, reduce misdiagnoses and improve access to personalised care. Stephanie Martlew, CEO at Psyomics, said: “We’re confident that together with the brilliant team at HPFT, the partnership will demonstrate the role that digital mental health tools can play in supporting clinicians and patients, and will catalyse adoption of these technologies to population level – ultimately helping more people into the right treatment pathway, first time.” The partnership hopes to increase clinical capacity in adult mental health services, improve the understanding of population mental health needs, increase efficiency and speed of assessment times, and ensure patients are on the right pathways first time. Through the platform clinicians gain a detailed view of an individual’s needs, helping to streamline the assessment process and ensure people get the treatment they need faster. This helps to ensure patients receive the correct treatment first time round, improving patient outcomes, whilst also freeing up clinician time. Patients are also fully involved with the assessment process and will be able to use the platform to complete assessments, working through them at their own pace. Hakan Akozek, chief information officer at HPFT, said: “The solution developed by Psyomics involves our service users right from the start, giving them the ability to share their stories at a time and place of their choosing prior to their appointment. “As our clinicians have access to this information before the appointment, we believe this will make initial assessments more meaningful and ultimately help us deliver better outcomes for our service users and carers.” In addition, Psyomics’ fully digital services gives NHS organisations powerful datasets showing mental health needs across an entire region and creates actionable, data-driving insights. If the two-year partnership is successful the initiative will be rolled out at ICS level.

Psyomics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Psyomics Rank

  • When was Psyomics founded?

    Psyomics was founded in 2015.

  • Where is Psyomics's headquarters?

    Psyomics's headquarters is located at Cambridge Innovation Centre, 23 Cambridge Science Park, Cambridge.

  • What is Psyomics's latest funding round?

    Psyomics's latest funding round is Unattributed VC - III.

  • How much did Psyomics raise?

    Psyomics raised a total of $4.9M.

  • Who are the investors of Psyomics?

    Investors of Psyomics include Parkwalk Advisors, Meltwind, Newable Private Investing, Jonathan Milner, Martlet Capital and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.